StemPoint Capital LP
- SEC CIK
- 0001952142
- Latest filing
- Aug 14, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by StemPoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −182,130−100.0% | Sold out | Holders |
| Q4 2025 | 182,130 | $1.00M | 0.2% | −657,539−78.3% | Reduced | Holders |
| Q3 2025 | 839,669 | $2.75M | 0.6% | −364,272−30.3% | Reduced | Holders |
| Q2 2025 | 1,203,941 | $2.78M | 0.9% | +1,203,941 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −1,087,785−100.0% | Sold out | Holders |
| Q1 2024 | 1,087,785 | $3.12M | 0.8% | +1,087,785 | New | Holders |